Abstract
We evaluated age at onset and transmission patterns of Alzheimer's disease (AD) in families of 198 patients who had onset of symptoms before the age of 65 years and were diagnosed before the age of 70 years. Patients were ascertained in a population based study in The Netherlands. The results suggest that the risk of AD by the age of 90 in first degree relatives is 39% (95% confidence interval 27 to 51). By the age of 90, this risk is 2.8 (95% confidence interval 1.5-5.2) times greater than the corresponding risk of 14% among relatives of age and sex matched control subjects. Segregation analysis indicated that patterns of familial clustering are best explained by transmission of a major autosomal dominant gene with reduced penetrance and a multifactorial component. However, the single major locus model could be rejected in favour of the mixed model only when a cohort effect for heritability was allowed for. The frequency of the AD susceptibility allele was estimated to be 0.48% in the single major locus model and 0.31% in the mixed model. Although our study confirms that a dominant major gene is implicated in early onset AD, the results suggest that other genetic or perhaps non-genetic factors may account for the disease in a considerable number of patients. The tendency for Alzheimer's disease (AD) to cluster in families is well recognised.' There is evidence for autosomal dominant inheritance in a considerable number of families with multiple affected members. 2 Identification of defects in the gene coding for ,B amyloid processing protein in patients from some families"7 and evidence for linkage of early onset familial AD (FAD) to chromosome 148-" and late onset FAD to chromosome 1912 has fuelled speculation that the familial component in AD is accounted for by genetic transmission. However, observations of sporadic occurrence in approximately 50% of AD cases,'3'6 similar concordance rates in the range of 50% for AD among MZ and DZ twin pairs,'7-'9 and a significantly higher number of patients with a positive family history of AD in first degree relatives among MZ twin pairs concordant for AD than in discordant MZ twins pairs20 suggest that the genetic susceptibility to AD in many people is either lacking or insufficient to cause symptoms. Differences in methodology may underlie this wide range in risk estimates. On the other hand, it is also conceivable that these discrepancies may be because of heterogeneity. 2' Interpretation of familial risk data from survey studies'42223 is difficult because of censoring of unaffected relatives. In other words, even elderly relatives who are unaffected at the time of the study may yet develop or could have developed the illness at a later age. Survival analysis studies2427 have quantified life time risk more accurately, but these methods are unable to distinguish an inherited risk factor from environmental transmission or discriminate between unifactorial and multifactorial disease models.
It has been suggested that genetics may differ between early and late onset AD and that the early onset form (onset before 65 The purpose of this study was to clarify the genetic transmission of early onset AD using data of a population based unbiased sample of AD patients. The study aimed to estimate the risk of AD for first degree relatives of patients with early onset AD and to delineate the mode of inheritance of early onset AD.
Methods

SUBJECTS
For this study, patients in whom the age at onset was before the age of 65 years and in whom the diagnosis of AD was made before the age of 70 years in the period of January 1980 to July 1987 were eligible. Details of the study design have been published earlier. 30 The study was population based and aimed at complete ascertainment of all cases with early onset AD living in two areas of The Netherlands (the four northern provinces and the region of the city of Rotterdam). All nursing homes, psychiatric institutions, social-geriatric services, neurologists, and facilities for computed tomography in the specified areas were asked for patients with dementia in order to obtain full ascertainment of early onset cases. The patients were then seen by two For each patient a reference subject was selected and matched for age (within five years), gender, and place of residence. These controls were drawn randomly from the population register of the municipality of the patient at the time of diagnosis. All control subjects had a SPMSQ score of 20 or over. For controls, the first person asked consented in 103 cases (52%), in 68 (34%) it was the second selected person, in 23 (12%) the third, and in four (2%) the fourth.
DATA COLLECTION
We did not examine the relatives of the probands because a considerable number of first degree relatives were already dead at the time of study. However, detailed data on family history were collected by interviewing a next of kin of the patient or control. This informant was asked specifically about the occurrence of dementia in all first degree relatives. To increase the validity of the family history data, the information was always verified by a sib of the patient or control. Four subjects born outside The Netherlands were excluded from the analysis because their sibs could not be contacted. Onset age of dementia was defined as the age at which memory loss or change in behaviour was first noted. For non-demented relatives, the censoring age was determined, that is, the age at time of the study or the age at death.
We questioned informants extensively on the cause and the course of the dementia in affected relatives. The diagnosis was checked in independent medical records for demented persons who had been admitted to a hospital. Because relatives may have been diagnosed before standardised diagnostic criteria were available, all relatives reported as demented were re-evaluated using data from multiple informants and information derived from medical records. Relatives with a history of neurological, psychiatric, or metabolic disorders that may also lead to dementia (for example, stroke, Parkinson's disease, epilepsy, depression, or alcoholism) were classified as unaffected. All other relatives with a type of dementia that was reported as being irreversible and progressive were classified as affected with possible AD. Medical records were available for 36 (32%) of the affected relatives. Pedigrees of the families are available upon request.
ESTIMATION OF LIFE TIME RISK AND AGE AT ONSET DISTRIBUTION
Risks of dementia and the age at onset distribution for first degree relatives of the AD probands and control subjects were estimated using a maximum likelihood procedure.35 This method considers not only affected persons with known onset ages and unaffected persons with known censoring ages (that is, those persons typically included in a Kaplan-Meier survival analysis36), but also persons for whom onset age or censoring age data are missing. This method also allows for the possibilities that a proportion of relatives asymptomatic at the time of study may be susceptible and express the disease later in life and that some dead relatives may have died from causes unrelated to AD although they may have developed symptoms had they survived. Parameter estimates for the estimated life time risk and mean onset age were compared between AD relatives and control relatives and among subgroups of AD relatives at the oldest onset age common to both groups. Since asymptotically these maximum likelihood statitics have normal distributions, a large sample Z statistic was used.37 For the purpose of these analyses, probands were stratified by age at onset of 58 years because this age was calculated using maximum likelihood as the most parsimonious cut off between families with early onset FAD as the sole mechanism for AD transmission cannot be excluded without doing a formal pedigree analysis. Other studies242643 have reported life time risks that approach 50%, but these values may be inflated because of estimation bias associated with a paucity of unaffected persons who survive to very late ages (sample size issue) and ascertainment biased towards cases with a positive family history. In contrast, the life time risk for AD of 39% is in remarkable agreement with the maximum risk estimate of 39% obtained by Farrer et al,27 despite the differences between the studies in ascertainment and age of onset of probands.
Although the risk of dementia was higher among parents than sibs at all ages, survival analysis also showed that life time risks to parents and sibs by the age of 81 were statistically indistinguishable, a finding consistent with other studies.2426 The raised risk to females is still apparent after adjusting for differential survival between men and women. Although this difference may reflect enhanced genetic expression among women,'924 the risk of 70% among female relatives of probands with onset < 58 years is higher than expected for autosomal dominant inheritance, suggesting the existence of excess phenocopies among women.
Other complex segregation analysis suggests that patterns of familial clustering are best explained by a mixed model, in which there is transmission of a major autosomal dominant gene and a multifactorial component. These findings are consistent with the results of the survival analysis in table 3. As Z is significantly greater than one, the polygenic component seems to be stronger in the parental generation than in the offspring generation in Dutch families. This trend is in agreement with the higher risk estimates for parents than for sibs at all ages (fig 2) . Biologically, the strong generational effect is difficult to interpret. It The evidence for a multifactorial effect is weak in our study of early onset AD, but this needs to be confirmed in independent studies.
Given the low frequency of the AD susceptibility allele and the lack of strong environmental risk factors, the origin of familial aggregation of AD in some families remains an unresolved issue. Other complex forms of genetic susceptibility not accounted for by the present methodology may be implicated. The finding of reduced penetrance for the major dominant allele in the present study is indeed compatible with an oligogenic model.
Our findings are also of interest in light of the recent linkage studies of familial AD. Familial early onset AD must be genetically heterogeneous, because the mutant gene in some families maps to chromosome 148--" whereas patients in other families have defects within the f amyloid processing protein gene located on chromosome 21 .1' Although the possibility of multiple loci has not been examined, our analysis and the segregation analysis by Farrer et aP29 predict that it is unlikely that one dominant allele underlies the genetic basis in all cases. The hypothesis that non-mendelian inheritance may be involved in the genetic transmission of AD is supported by the finding of a strong association between Apo E4 and late onset AD. 57 A challenge to genetic epidemiologists in the future may be to disentangle the various genetic and non-genetic factors implicated in AD. Oligogenic models and epistatic models are still to be explored. A profitable strategy in future research may be to incorporate existing clues about the multifactorial component, such as associations with the Apo E4,57 HLA-A2,58 age of the father at the time of birth,59 and other risk factors,6' in a regressive model analysis.6' In this way, it may be possible to distinguish meaningful subgroups which would be useful for a variety of clinical and research applications.
